Recombinant Human F9 Protein, GMP Grade
Product Specifications
CAS Number
9000-83-3
eClass Product Group
Protein
Origin
Human
Applications
The product is indicated for the use in adults and children with hemophilia B for control and prevention of bleeding episodes, routine prophylaxis and perioperative management. In the EMA approval, it is also indicated for on-demand treatment of bleeding episodes. Hemophilia B is characterized by a deficiency in the coagulation factor IX which results in prolonged oozing after injuries and delayed or recurring bleeding prior wound healing. Hemophilia B patients present more frequent bleeding episodes during childhood and adolescence than in adulthood.
Shipping Conditions
Ice packs
Documents
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items